These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

673 related articles for article (PubMed ID: 25937281)

  • 1. Efficient CRISPR-Cas9-mediated generation of knockin human pluripotent stem cells lacking undesired mutations at the targeted locus.
    Merkle FT; Neuhausser WM; Santos D; Valen E; Gagnon JA; Maas K; Sandoe J; Schier AF; Eggan K
    Cell Rep; 2015 May; 11(6):875-883. PubMed ID: 25937281
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pipeline for the Generation and Characterization of Transgenic Human Pluripotent Stem Cells Using the CRISPR/Cas9 Technology.
    Mianné J; Bourguignon C; Nguyen Van C; Fieldès M; Nasri A; Assou S; De Vos J
    Cells; 2020 May; 9(5):. PubMed ID: 32466123
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A Cas9 Variant for Efficient Generation of Indel-Free Knockin or Gene-Corrected Human Pluripotent Stem Cells.
    Howden SE; McColl B; Glaser A; Vadolas J; Petrou S; Little MH; Elefanty AG; Stanley EG
    Stem Cell Reports; 2016 Sep; 7(3):508-517. PubMed ID: 27499201
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comprehensive Protocols for CRISPR/Cas9-based Gene Editing in Human Pluripotent Stem Cells.
    Santos DP; Kiskinis E; Eggan K; Merkle FT
    Curr Protoc Stem Cell Biol; 2016 Aug; 38():5B.6.1-5B.6.60. PubMed ID: 27532820
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Efficient genome editing in human pluripotent stem cells through CRISPR/Cas9].
    Liu GG; Li S; Wei YD; Zhang YX; Ding QR
    Yi Chuan; 2015 Nov; 37(11):1167-73. PubMed ID: 26582531
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Human Induced Pluripotent Stem Cell NEUROG2 Dual Knockin Reporter Lines Generated by the CRISPR/Cas9 System.
    Li S; Xue H; Wu J; Rao MS; Kim DH; Deng W; Liu Y
    Stem Cells Dev; 2015 Dec; 24(24):2925-42. PubMed ID: 26414932
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Generation of Defined Genomic Modifications Using CRISPR-CAS9 in Human Pluripotent Stem Cells.
    Cardenas-Diaz FL; Maguire JA; Gadue P; French DL
    J Vis Exp; 2019 Sep; (151):. PubMed ID: 31609348
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A Scaled Framework for CRISPR Editing of Human Pluripotent Stem Cells to Study Psychiatric Disease.
    Hazelbaker DZ; Beccard A; Bara AM; Dabkowski N; Messana A; Mazzucato P; Lam D; Manning D; Eggan K; Barrett LE
    Stem Cell Reports; 2017 Oct; 9(4):1315-1327. PubMed ID: 29020615
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An episomal vector-based CRISPR/Cas9 system for highly efficient gene knockout in human pluripotent stem cells.
    Xie Y; Wang D; Lan F; Wei G; Ni T; Chai R; Liu D; Hu S; Li M; Li D; Wang H; Wang Y
    Sci Rep; 2017 May; 7(1):2320. PubMed ID: 28539611
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Semi-automated optimized method to isolate CRISPR/Cas9 edited human pluripotent stem cell clones.
    Frank E; Cailleret M; Nelep C; Fragner P; Polentes J; Herardot E; El Kassar L; Giraud-Triboult K; Monville C; Ben M'Barek K
    Stem Cell Res Ther; 2023 Apr; 14(1):110. PubMed ID: 37106426
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Developing CRISPR/Cas9-Mediated Fluorescent Reporter Human Pluripotent Stem-Cell Lines for High-Content Screening.
    Vojnits K; Nakanishi M; Porras D; Kim Y; Feng Z; Golubeva D; Bhatia M
    Molecules; 2022 Apr; 27(8):. PubMed ID: 35458632
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Engineering Human Stem Cell Lines with Inducible Gene Knockout using CRISPR/Cas9.
    Chen Y; Cao J; Xiong M; Petersen AJ; Dong Y; Tao Y; Huang CT; Du Z; Zhang SC
    Cell Stem Cell; 2015 Aug; 17(2):233-44. PubMed ID: 26145478
    [TBL] [Abstract][Full Text] [Related]  

  • 13. p53 inhibits CRISPR-Cas9 engineering in human pluripotent stem cells.
    Ihry RJ; Worringer KA; Salick MR; Frias E; Ho D; Theriault K; Kommineni S; Chen J; Sondey M; Ye C; Randhawa R; Kulkarni T; Yang Z; McAllister G; Russ C; Reece-Hoyes J; Forrester W; Hoffman GR; Dolmetsch R; Kaykas A
    Nat Med; 2018 Jul; 24(7):939-946. PubMed ID: 29892062
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fast and Quantitative Identification of Ex Vivo Precise Genome Targeting-Induced Indel Events by IDAA.
    König S; Yang Z; Wandall HH; Mussolino C; Bennett EP
    Methods Mol Biol; 2019; 1961():45-66. PubMed ID: 30912039
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Genome editing with the donor plasmid equipped with synthetic crRNA-target sequence.
    Ishibashi R; Abe K; Ido N; Kitano S; Miyachi H; Toyoshima F
    Sci Rep; 2020 Aug; 10(1):14120. PubMed ID: 32839482
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Generating CRISPR-Cas9-Mediated Null Mutations and Screening Targeting Efficiency in Human Pluripotent Stem Cells.
    Bower OJ; McCarthy A; Lea RA; Alanis-Lobato G; Zohren J; Gerri C; Turner JMA; Niakan KK
    Curr Protoc; 2021 Aug; 1(8):e232. PubMed ID: 34432381
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Unexpected genomic rearrangements at targeted loci associated with CRISPR/Cas9-mediated knock-in.
    Rezza A; Jacquet C; Le Pillouer A; Lafarguette F; Ruptier C; Billandon M; Isnard Petit P; Trouttet S; Thiam K; Fraichard A; Chérifi Y
    Sci Rep; 2019 Mar; 9(1):3486. PubMed ID: 30837594
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficient introduction of specific homozygous and heterozygous mutations using CRISPR/Cas9.
    Paquet D; Kwart D; Chen A; Sproul A; Jacob S; Teo S; Olsen KM; Gregg A; Noggle S; Tessier-Lavigne M
    Nature; 2016 May; 533(7601):125-9. PubMed ID: 27120160
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Precise and efficient scarless genome editing in stem cells using CORRECT.
    Kwart D; Paquet D; Teo S; Tessier-Lavigne M
    Nat Protoc; 2017 Feb; 12(2):329-354. PubMed ID: 28102837
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Highly Efficient CRISPR/Cas9-Mediated Genome Editing in Human Pluripotent Stem Cells.
    Maguire JA; Gadue P; French DL
    Curr Protoc; 2022 Nov; 2(11):e590. PubMed ID: 36426905
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 34.